Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jürgen Scholze

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Herz|May 29, 2004
[Pulse pressure in the therapeutic management of hypertension?]Jürgen Scholze
Expert Opinion on Drug Safety|January 25, 2011
Safety and efficacy of olmesartan: an observational pooled-analysis of 156,682 hypertensive patientsJürgen Scholze, Angie Schaefer, Reinhold Kreutz
MMW Fortschritte Der Medizin|October 25, 2007
[Cardiometabolic high risk patients with abdominal obesity. Frequency and risk factor profile in primary care]Jürgen Scholze, Wolfgang Lilienthal, Peter Bramlage
Medicine and Science in Sports and Exercise|January 7, 2004
Regular exercise as an effective approach in antihypertensive therapyReinhard G Ketelhut, Ingomar W Franz, Jürgen Scholze
Fundamental & Clinical Pharmacology|August 8, 2009
Pharmacokinetics and safety of olmesartan medoxomil in combination with either amlodipine or atenolol compared to respective monotherapies in healthy subjectsJuliane Bolbrinker, Matthias Huber, Jürgen Scholze, et al.
Expert Opinion on Pharmacotherapy|October 18, 2011
Efficacy and safety of a fixed-dose combination of lercanidipine and enalapril in daily practice. A comparison of office, self-measured and ambulatory blood pressureJürgen Scholze, Peter Bramlage, Peter Trenkwalder, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 16, 2015
Adding Hydrochlorothiazide to Olmesartan/Amlodipine Increases Efficacy in Patients With Inadequate Blood Pressure Control on Dual-Combination TherapyLars C Rump, Bettina Ammentorp, Petra Laeis, et al.
Current Medical Research and Opinion|June 4, 2014
Impact of socio-economic factors on the long-term effectiveness of antihypertensive treatment with an angiotensin II receptor blocker: an observational studyJürgen Scholze, Alexander Weinstock, Florian Kirchner, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 1, 2007
Effects of the angiotensin II type 1 receptor antagonist telmisartan on monocyte adhesion and activation in patients with essential hypertensionUta Syrbe, Anja Moebes, Jürgen Scholze, et al.
Circulation|April 4, 2007
Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) studyJürgen Scholze, Elmar Grimm, Dana Herrmann, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Herz|May 29, 2004
[Pulse pressure in the therapeutic management of hypertension?]Jürgen Scholze
Expert Opinion on Drug Safety|January 25, 2011
Safety and efficacy of olmesartan: an observational pooled-analysis of 156,682 hypertensive patientsJürgen Scholze, Angie Schaefer, Reinhold Kreutz
MMW Fortschritte Der Medizin|October 25, 2007
[Cardiometabolic high risk patients with abdominal obesity. Frequency and risk factor profile in primary care]Jürgen Scholze, Wolfgang Lilienthal, Peter Bramlage
Medicine and Science in Sports and Exercise|January 7, 2004
Regular exercise as an effective approach in antihypertensive therapyReinhard G Ketelhut, Ingomar W Franz, Jürgen Scholze
Fundamental & Clinical Pharmacology|August 8, 2009
Pharmacokinetics and safety of olmesartan medoxomil in combination with either amlodipine or atenolol compared to respective monotherapies in healthy subjectsJuliane Bolbrinker, Matthias Huber, Jürgen Scholze, et al.
Expert Opinion on Pharmacotherapy|October 18, 2011
Efficacy and safety of a fixed-dose combination of lercanidipine and enalapril in daily practice. A comparison of office, self-measured and ambulatory blood pressureJürgen Scholze, Peter Bramlage, Peter Trenkwalder, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 16, 2015
Adding Hydrochlorothiazide to Olmesartan/Amlodipine Increases Efficacy in Patients With Inadequate Blood Pressure Control on Dual-Combination TherapyLars C Rump, Bettina Ammentorp, Petra Laeis, et al.
Current Medical Research and Opinion|June 4, 2014
Impact of socio-economic factors on the long-term effectiveness of antihypertensive treatment with an angiotensin II receptor blocker: an observational studyJürgen Scholze, Alexander Weinstock, Florian Kirchner, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 1, 2007
Effects of the angiotensin II type 1 receptor antagonist telmisartan on monocyte adhesion and activation in patients with essential hypertensionUta Syrbe, Anja Moebes, Jürgen Scholze, et al.
Circulation|April 4, 2007
Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) studyJürgen Scholze, Elmar Grimm, Dana Herrmann, et al.
Pageof 3